Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

3.08
-0.0400-1.28%
Post-market: 3.120.0400+1.30%19:30 EDT
Volume:682.28K
Turnover:2.11M
Market Cap:256.90M
PE:-2.20
High:3.21
Open:3.15
Low:3.02
Close:3.12
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:49.56M
Volume Ratio:1.01
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:22.46
PE(LYR):-2.40

Loading ...

Pyxis Oncology Stockholders Approve Directors and Auditor Slate

TIPRANKS
·
Jun 16

Pyxis Oncology holds annual shareholder meeting via webcast

Reuters
·
Jun 16

Pyxis Oncology (PYXS) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 23

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS) and Actuate Therapeutics, Inc. (ACTU)

TIPRANKS
·
May 18

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

RBC Capital Keeps Their Buy Rating on Pyxis Oncology (PYXS)

TIPRANKS
·
May 15

Pyxis Oncology (PYXS) Gets a Buy from Guggenheim

TIPRANKS
·
May 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Pyxis Oncology (PYXS) and Candel Therapeutics (CADL)

TIPRANKS
·
May 15

Pyxis Oncology Faces Urgent Capital Needs and Potential Dilution Risks Amid Market Volatility

TIPRANKS
·
May 15

Pyxis Oncology Shares Slide on Steeper 1Q Loss

Dow Jones
·
May 15

Pyxis Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Pyxis Oncologyreports Q1 EPS (37c), consensus (35c)

TIPRANKS
·
May 14

Pyxis Oncology Q1 EPS $(0.37), Inline

Benzinga Earnings
·
May 14

Pyxis Oncology Q1 Net Income USD -23.272 Million

Reuters
·
May 14

Pyxis Oncology Q1 net loss widens on higher clinical trial costs

Reuters
·
May 14

Pyxis Oncology Q1 Income From Operations USD -24.36 Million

THOMSON REUTERS
·
May 14

Pyxis Oncology Q1 EPS USD -0.37

THOMSON REUTERS
·
May 14

Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
May 14

Press Release: Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
May 14

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 13